strategi
improv
onset
protect
immun
induc
vaccin
respiratori
pathogen
may
signific
impact
health
newli
receiv
beef
calv
object
determin
use
inject
trace
miner
itm
se
zn
cu
mn
concurr
modifiedl
viru
mlv
vaccin
enhanc
immun
respons
onset
protect
beef
calv
challeng
five
day
vaccin
fortyf
calv
randomli
assign
one
three
group
vacitm
receiv
mlvvaccin
itm
multimin
subcutan
sc
vacsal
receiv
vaccin
salin
sc
unvac
unvaccin
five
day
vaccin
calv
challeng
strain
health
statu
evalu
blood
sampl
collect
leukocyt
count
serum
neutral
antibodi
sna
bvdvpcr
percentag
tcell
vacitm
lower
health
score
unvac
j
u
r
n
l
p
r
e
p
r
f
vacitm
higher
sna
titer
vacsal
unvac
lymphocyt
count
decreas
unvac
vacitm
vacsal
tcell
significantli
decreas
unvac
vacsal
vacitm
higher
percentag
cell
unvac
vacitm
lower
percentag
activ
unvac
summari
vaccin
induc
rapid
protect
infect
administr
itm
associ
increas
sna
respons
enhanc
health
statu
mitig
tcell
decreas
reduct
tcell
activ
calv
challeng
five
day
immun
result
support
strateg
use
itm
concurr
vaccin
especi
rapid
protect
need
newli
receiv
beef
calv
spread
viru
herd
diagnosi
cull
persist
infect
anim
alli
vaccin
brock
et
al
walz
et
al
vaccin
attenu
inactiv
vaccin
effici
tool
prevent
lessen
impact
bvdv
infect
dean
leyh
newcom
et
al
despit
commerci
avail
sever
highli
efficaci
vaccin
usa
signific
number
produc
vaccin
calv
bvdv
brd
pathogen
efficaci
vaccin
prevent
bvdv
infect
assess
vaccin
capac
induc
robust
humor
cellmedi
immun
respons
abl
control
viru
replic
viremia
shed
rhode
et
al
reber
et
al
anoth
crucial
aspect
assess
efficaci
brd
vaccin
rapid
induc
adequ
immun
respons
protect
cattl
acut
infect
diseas
palomar
et
al
trait
especi
import
stockyard
feedlot
continu
addit
highli
stress
cattl
unknown
vaccin
histori
infecti
statu
rise
risk
infect
clinic
diseas
result
high
morbid
mortal
rate
signific
econom
loss
previou
studi
character
onset
protect
induc
modifiedl
viru
mlv
vaccin
administ
day
bvdv
challeng
high
low
virul
bvdv
strain
brock
et
al
palomar
et
al
trial
calv
vaccin
day
bvdv
challeng
protect
clinic
diseas
viremia
leukopenia
viru
shed
compar
unvaccin
calv
brock
et
al
palomar
et
al
trial
perform
control
experiment
condit
low
stress
level
infecti
pressur
ensur
appropri
anim
comfort
welfar
stressor
impos
calv
abrupt
wean
lack
precondit
weather
extrem
irregular
vaccin
long
transport
comingl
excess
locat
diet
chang
compromis
immun
j
u
r
n
l
p
r
e
p
r
f
function
respons
vaccin
due
oxid
stress
affect
anim
health
perform
moreov
current
global
pressur
reduc
antibiot
use
food
anim
product
creat
need
vaccin
protocol
induc
enhanc
protect
limit
diseas
transmiss
effici
numer
studi
proven
effect
trace
miner
selenium
se
zinc
zn
copper
cu
manganes
mn
immun
chiras
et
al
perciv
underwood
suttl
health
growth
perform
cattl
spear
kegley
impact
miner
immun
function
associ
role
structur
function
antioxid
enzym
eg
superoxid
dismutas
glutathion
peroxidas
nucleic
acid
replic
transcript
mitochondri
metabol
cascad
among
other
tomlinson
et
al
haas
rink
result
improv
neutrophil
migrat
phagocyt
function
lymphocyt
prolifer
antibodi
product
pina
et
al
tomlinson
et
al
arthington
havenga
haas
rink
bonaventura
et
al
use
trace
miner
supplement
may
becom
particularli
import
highli
stress
cattl
newli
receiv
feeder
calv
duff
galyean
administr
inject
trace
miner
itm
shown
benefici
effect
antibodi
product
cell
mediat
immun
respons
brd
vaccin
beef
arthington
havenga
robert
et
al
dairi
cattl
palomar
et
al
bittar
et
al
recent
studi
develop
group
demonstr
use
itm
concomit
mlvbrd
vaccin
dairi
calv
result
earlier
greater
serum
neutral
antibodi
titer
mannheimia
haemolytica
rapid
stronger
mononuclear
cell
prolifer
upon
stimul
brsv
pasteurella
multocida
control
calv
palomar
et
al
bittar
et
al
studi
question
whether
use
itm
could
also
favor
j
u
r
n
l
p
r
e
p
r
f
induct
rapid
improv
immun
respons
protect
shortli
vaccin
situat
fast
protect
requir
newli
receiv
calv
vaccin
arriv
shortli
expos
brd
pathogen
therefor
present
studi
hypothes
administr
itm
time
mlvbrd
vaccin
would
benefit
immun
respons
protect
newli
receiv
beef
calv
experiment
challeng
bvdv
five
day
vaccin
object
studi
determin
use
inject
trace
miner
contain
se
zn
cu
mn
supplement
concurr
modifiedl
viru
mlv
vaccin
abl
enhanc
immun
respons
onset
protect
experiment
infect
newli
receiv
beef
calv
challeng
day
vaccin
studi
done
univers
georgia
uga
ocone
farm
watkinsvillega
may
june
research
protocol
approv
univers
georgia
institut
anim
care
use
committe
ugaaup
studi
perform
use
wean
angu
anguscrossbr
calv
month
old
purchas
commerci
ranch
calhoun
ga
calv
confirm
via
standard
viru
neutral
test
serum
neutral
antibodi
sna
titer
ear
notch
biopsi
immunohistochemistri
bvdv
antigen
done
univers
georgia
athen
veterinari
diagnost
laboratori
athen
ga
calv
dam
vaccin
brd
vaccin
farm
origin
begin
studi
order
maintain
calv
statu
addit
calv
dam
kept
j
u
r
n
l
p
r
e
p
r
f
isol
pastur
away
main
herd
birth
wean
avoid
contact
mlv
vaccin
cattl
farm
origin
calv
graze
rye
grass
lolium
hybridum
free
access
bermuda
grass
hay
cynodon
dactylon
water
ad
libitum
day
calv
transport
approxim
hour
farm
origin
calhoun
ga
ocone
farm
colleg
veterinari
medicin
univers
georgia
uga
watkinsvil
ga
experiment
farm
calv
graze
fescu
grass
festuca
arundinacea
free
access
bermuda
grass
hay
cynodon
dactylon
water
ad
libitum
addit
calv
supplement
kg
per
calfday
commerci
ration
contain
trace
miner
cattleman
special
beef
godfrey
warehous
madisonga
offer
two
meal
addit
oral
miner
supplement
provid
studi
day
calv
randomli
assign
one
three
group
vacitm
n
calv
receiv
ml
mlv
vaccin
contain
brsv
stock
strain
util
trial
biolog
clone
use
success
passag
previous
describ
bittar
et
al
strain
previous
proven
success
induc
lymphopenia
neutrophilia
mild
moder
clinic
diseas
nonvaccin
calv
walz
et
al
bittar
et
al
manassa
va
previous
describ
bittar
et
al
inocula
remain
frozen
day
challeng
one
hour
challeng
frozen
inoculum
thaw
ml
inoculum
aliquot
individu
ml
steril
syring
transport
farm
held
ice
use
challeng
done
intranas
aerosol
ml
inoculum
ml
nostril
cm
long
tipfenestr
cannula
coupl
ml
syring
individu
anim
previous
describ
bittar
et
al
j
u
r
n
l
p
r
e
p
r
f
challeng
calv
comingl
pastur
adequ
shade
rest
experiment
period
sampl
ml
inoculum
transport
ice
lab
determin
viru
concentr
challeng
finish
calv
health
statu
compris
rectal
temperatur
hydrat
attitud
eye
nasal
discharg
fecal
consist
assess
use
univers
wisconsin
score
system
http
clinic
examin
perform
calf
studi
day
rel
day
bvdv
challeng
howev
rectal
temperatur
measur
studi
day
clinic
sign
assess
variabl
hydrat
statu
nasal
secret
headear
attitud
fece
eye
cough
scale
repres
lack
clinic
sign
repres
sever
clinic
sign
daili
sum
health
score
total
sum
individu
clinic
sign
calcul
ad
individu
score
six
clinic
variabl
previous
describ
bittar
et
al
three
experienc
veterinarian
awar
calv
treatment
alloc
assess
clinic
sign
health
score
blood
sampl
collect
jugular
vein
use
gaug
x
singl
sampl
needl
nipro
medic
industri
ltd
gunma
japan
vacuum
tube
bd
diagnosi
franklin
lake
nj
without
anticoagul
obtain
whole
blood
serum
respect
blood
sampl
collect
studi
day
j
u
r
n
l
p
r
e
p
r
f
blood
collect
done
four
individu
ml
glass
tube
buffi
coat
separ
bd
vacutain
acd
solut
bd
diagnosi
franklin
lake
nj
one
ml
polypropylen
tube
leukocyt
platelet
count
bd
vacutain
edta
bd
diagnosi
franklin
lake
nj
addit
blood
sampl
collect
two
individu
ml
glass
tube
without
anticoagul
bd
vacutain
bd
diagnosi
franklin
lake
nj
serum
miner
concentr
serum
neutral
antibodi
sna
titer
blood
sampl
contain
acd
solut
process
buffi
coat
isol
previous
describ
harpin
et
al
freshli
use
stain
flow
cytometri
analysi
store
c
real
time
quantit
revers
transcript
polymeras
chain
reaction
qrtpcr
nucleic
acid
detect
clot
blood
sampl
centrifug
g
serum
separ
serum
sampl
store
c
determin
sna
titer
nasal
swab
sampl
collect
calf
bvdv
nucleic
acid
detect
use
qrtpcr
studi
day
individu
cotton
swab
insert
nostril
scrape
nasal
mucosa
place
tube
contain
ml
pb
penicillinstreptomycin
amphotericin
transport
laboratori
process
previous
describ
bittar
et
al
sampl
mix
use
vortex
swab
remov
solut
filter
store
c
subsequ
qrtpcr
trace
miner
statu
liver
biopsi
sampl
mg
liver
tissu
assess
calf
day
rel
day
vaccin
liver
biopsi
collect
use
steril
surgic
trucut
semiautomat
biopsi
needl
g
four
inch
long
assist
ultrasonographi
ei
imag
loveland
co
liver
visual
blood
sampl
serum
neutral
antibodi
sna
titer
collect
day
serum
neutral
antibodi
titer
determin
univers
georgia
athen
veterinari
diagnost
laboratori
athen
ga
via
standard
viru
neutral
protocol
previous
describ
bittar
et
al
summari
heat
inactiv
serum
sampl
c
min
serum
sampl
serial
dilut
dmem
dilut
seri
begin
cell
cultur
plate
equal
volum
appropri
cytopath
ad
well
dmem
approxim
respect
virus
strain
make
start
serum
dilut
incub
c
h
mdbk
cell
suspens
ad
well
suspens
approxim
x
cell
dmem
contain
fetal
calf
serum
fc
cell
monolay
examin
invert
microscop
sign
virusspecif
cytopath
effect
plate
incub
day
c
sna
titer
sampl
report
reciproc
highest
dilut
serum
complet
inhibit
virusinduc
cytopath
effect
j
u
r
n
l
p
r
e
p
r
f
blood
sampl
total
white
blood
cell
lymphocyt
granulocyt
monocyt
platelet
count
collect
day
tube
uncoagul
blood
sampl
contain
edta
kept
cool
ice
posteriorli
transport
depart
veterinari
patholog
univers
georgia
uga
athen
ga
complet
blood
count
cbc
blood
sampl
kept
room
temperatur
orbit
shaker
stir
minut
analysi
total
leukocyt
platelet
differenti
leukocyt
count
sampl
determin
use
automat
cell
counter
cbcdiff
vet
hematolog
system
de
moin
ia
blood
sampl
tcell
phenotyp
includ
express
collect
day
blood
sampl
buffi
coat
prepar
leukocyt
assess
cell
viabil
exclus
trypan
blue
cell
number
use
hemocytomet
chamber
cell
suspend
concentr
approxim
cell
per
ml
sampl
viabil
greater
sampl
dilut
ml
individu
prelabel
tube
mm
polystyren
falcon
bd
bioscienc
san
ca
cell
wash
twice
centrifug
x
g
minut
supernat
discard
wash
cell
suspend
ml
fac
buffer
pb
bovin
serum
albumin
sodium
azid
mix
uniformli
vortex
stain
cell
suspens
approxim
cell
ad
per
well
round
bottom
microtit
plate
plate
centrifug
x
g
minut
snap
sharpli
remov
supernat
plate
vortex
lid
suspend
cell
residu
volum
point
antibodi
test
minimum
satur
concentr
j
u
r
n
l
p
r
e
p
r
f
ad
desir
well
well
dual
stain
combin
either
primari
antibodi
mous
antibovin
isotyp
antibodi
dilut
clone
biorad
hercul
ca
mous
antibovin
isotyp
antibodi
dilut
clone
biorad
hercul
ca
mous
antibovin
gammadelta
cell
isotyp
antibodi
dilut
clone
biorad
hercul
ca
mous
antibovin
isotyp
antibodi
dilut
clone
fac
buffer
ad
well
function
unstain
control
combin
tcell
antibodi
use
stain
cell
plate
incub
c
minut
follow
stain
plate
wash
three
time
fac
buffer
x
g
minut
end
wash
plate
snap
sharpli
remov
supernat
plate
vortex
lid
suspend
cell
residu
volum
last
wash
supernat
discard
cell
suspend
fac
fix
formalin
fac
buffer
well
receiv
fac
fix
plate
incub
overnight
hour
c
well
content
transfer
prelabel
ml
microcentrifug
tube
mct
contain
fac
buffer
dilut
fac
buffer
sampl
store
flow
cytometri
analysi
sampl
assess
within
one
week
fixat
flow
cytometri
done
use
bd
accuri
first
gener
cytomet
cflow
plu
softwar
bd
bioscienc
franklin
lake
nj
sampl
gate
use
fal
two
paramet
histogram
identifi
lymphocyt
monocyt
granulocyt
cell
sampl
base
previou
valid
highli
enrich
popul
compens
minim
cross
talk
signal
establish
use
singl
color
sampl
minimum
satur
concentr
elimin
green
orang
orang
green
color
bleed
posit
j
u
r
n
l
p
r
e
p
r
f
neg
window
singl
color
analysi
dual
paramet
histogram
establish
preliminari
trial
use
staphylococc
enterotoxin
b
stimul
buffi
coat
cell
stain
condit
set
templat
flow
collect
approxim
event
record
lymphocyt
gate
sampl
follow
data
collect
lymphocyt
gate
confirm
use
list
mode
data
sampl
assur
popul
measur
sampl
across
total
experi
cflow
plu
softwar
use
gener
valu
percent
posit
cell
marker
posit
cell
within
marker
addit
valu
mean
fluoresc
intens
gener
analysi
gate
marker
popul
within
marker
sampl
trial
buffi
coat
nasal
swab
sampl
store
c
thaw
room
temperatur
bvdv
nucleic
acid
detect
total
rna
extract
buffi
coat
nasal
swab
solut
use
rneasi
mini
kit
qiagen
germantown
md
total
rna
sampl
submit
athen
veterinari
diagnost
laboratori
multiplex
qrtpcr
perform
previous
describ
letelli
kerkhof
total
rna
sampl
revers
transcrib
presenc
hexanucleotid
one
microlit
result
cdna
use
realtim
pcr
analysi
letelli
kerkhof
base
conserv
region
utr
primer
pair
rectal
temperatur
increas
unvac
group
challeng
peak
day
fig
unvaccin
calv
significantli
higher
rectal
temperatur
vaccin
group
day
bvdv
challeng
p
differ
rectal
temperatur
vaccin
group
experiment
period
sum
daili
health
score
increas
day
post
bvdv
challeng
unvac
group
fig
mean
total
leukocyt
count
significantli
decreas
unvac
group
day
day
approx
fig
remain
low
day
valu
significantli
lower
j
u
r
n
l
p
r
e
p
r
f
vaccin
group
p
vaccin
group
treat
itm
similar
mean
leukocyt
count
along
studi
mean
lymphocyt
granulocyt
monocyt
count
significantli
decreas
unvac
group
day
bvdv
challeng
p
fig
statist
differ
vaccin
group
day
calv
vaccin
group
slight
decreas
lymphocyt
granulocyt
monocyt
count
vaccin
day
bvdv
challeng
signific
differ
group
fig
platelet
count
significantli
declin
bvdv
challeng
unvac
calv
day
fig
differ
platelet
count
increas
vacitm
group
day
remain
unaffect
vacsal
group
vaccin
calv
treat
itm
significantli
higher
platelet
count
compar
vacsal
day
p
unvac
calv
day
p
fig
serum
neutralizingantibodi
sna
titer
low
challeng
day
group
fig
sna
titer
dramat
increas
within
two
week
bvdv
challeng
vaccin
group
fig
calv
vacitm
higher
sna
titer
day
compar
vacsal
group
p
unvaccin
calv
lower
sna
titer
challeng
vaccin
group
p
moder
increas
approx
sna
titer
day
post
challeng
unvac
group
fig
moreov
sna
titer
dramat
increas
vacitm
vacsal
group
day
respect
fig
calv
vacitm
group
higher
sna
titer
compar
group
day
p
calv
unvac
group
j
u
r
n
l
p
r
e
p
r
f
also
rise
sna
titer
approx
day
bvdv
challeng
significantli
lower
vacitm
vacsal
group
p
current
studi
vaccin
provid
rapid
protect
experiment
infect
newlyreceiv
beef
calv
efficaci
vaccin
demonstr
lesser
health
score
associ
improv
health
statu
accord
evalu
system
use
low
high
virul
bvdv
day
primari
vaccin
brock
et
al
palomar
et
al
studi
demonstr
rapid
protect
bvdv
acut
infect
vaccin
given
day
challeng
howev
high
percentag
calv
j
u
r
n
l
p
r
e
p
r
f
challeng
day
vaccin
shed
bvdv
least
context
bvdv
prevent
result
previou
studi
brock
et
al
palomar
et
al
show
adequ
immun
respons
rapid
protect
elicit
vaccin
provid
evid
may
support
strateg
vaccin
time
cattl
arriv
reduc
quarantin
period
interv
vaccin
commingl
cattl
might
facilit
farm
manag
practic
studi
test
strategi
use
itm
concurr
vaccin
attempt
improv
protect
immun
respons
bvdv
newli
receiv
beef
calv
challeng
day
vaccin
sever
bvdvinduc
leukopenia
thrombocytopenia
observ
caus
mild
fatal
bronchiti
pneumonia
brogden
guthmil
reduct
platelet
number
common
hematolog
find
infect
strain
associ
hemorrhag
syndrom
rebhun
et
al
administr
itm
observ
previou
trial
evalu
longterm
protect
elicit
mlv
vaccin
itm
supplement
infect
dairi
calv
bittar
et
al
commerci
vaccin
use
studi
abl
reduc
viremia
viral
shed
bvdv
infect
repres
lower
number
posit
buffi
coat
nasal
swab
sampl
vaccin
group
day
experiment
challeng
compar
unvaccin
group
agreement
previou
studi
use
differ
bvdv
strain
brock
et
al
palomar
et
al
howev
supplement
itm
show
addit
benefici
effect
reduc
bvdv
detect
peripher
leukocyt
nasal
swab
sampl
humor
immun
respons
post
bvdv
challeng
greater
vaccin
group
compar
unvaccin
calv
calv
treat
itm
greater
sna
titer
compar
group
previou
field
studi
shown
associ
higher
sna
titer
health
perform
calv
feedlot
receiv
fulton
et
al
campbel
product
neutral
antibodi
one
major
featur
would
interest
includ
itm
alon
group
experiment
design
test
effect
itm
administr
immun
respons
challeng
itm
administr
suggest
improv
gener
health
statu
young
calv
teixeira
et
al
howev
administr
itm
intend
induc
specif
protect
immun
respiratori
pathogen
replac
vaccin
summari
mlvbrd
vaccin
concurr
itm
induc
rapid
protect
bvdv
infect
addit
administr
itm
time
vaccin
associ
increas
humor
immun
respons
enhanc
health
statu
appear
mitig
decreas
percentag
peripher
blood
circul
cell
reduc
activ
beef
calv
challeng
five
day
vaccin
moreov
administr
itm
time
vaccin
associ
significantli
increas
platelet
count
bvdv
challeng
result
support
strateg
use
itm
concurr
vaccin
protocol
especi
rapid
immun
respons
protect
need
newli
receiv
beef
calv
author
articl
declar
conflict
interest
hoek
rutten
vp
kool
j
arkesteijn
gj
bouwstra
rj
van
rhijn
koet
ap
subpopul
bovin
cell
rather
high
cell
act
immun
regulatori
cell
ex
vivo
vet
re
howard
error
bar
repres
sem
x
z
signific
differ
group
studi
day
p
studi
day
individu
challeng
ncp
strain
five
day
later
day
error
bar
repres
sem
x
z
signific
differ
group
studi
day
p
cumul
repres
total
number
calv
least
one
posit
bvdv
pcr
result
day
calv
group
calf
test
posit
one
day
count
